Evidence map›Paper›PMID 38476236›Full record

ArticleFrontiers in immunology2024

Integrative analysis identifies oxidative stress biomarkers in non-alcoholic fatty liver disease via machine learning and weighted gene co-expression network analysis.

Haining Wang, Wei Cheng, Ping Hu, Tao Ling, Chao Hu, Yongzhen Chen, Yanan Zheng, Junqi Wang, Ting Zhao, Qiang You

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Haining WangMedical Center for Digestive Diseases, Department of Geriatrics, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Wei ChengMedical Center for Digestive Diseases, Department of Geriatrics, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Ping HuDepartment of Orthopedics, Tianjin Medical University General Hospital, Tianjin, China.
Tao LingMedical Center for Digestive Diseases, Department of Geriatrics, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Chao HuMedical Center for Digestive Diseases, Department of Geriatrics, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Yongzhen ChenMedical Center for Digestive Diseases, Department of Geriatrics, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Yanan ZhengMedical Center for Digestive Diseases, Department of Geriatrics, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Junqi WangDepartment of Medical Oncology, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, China.
Ting ZhaoDepartment of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Qiang YouMedical Center for Digestive Diseases, Department of Geriatrics, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Second Affiliated Hospital of Nanjing Medical University · CNFudan University Shanghai Cancer Center · CNShenzhen Pingle Orthopedic Hospital · CNTianjin Medical University General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease globally, with the potential to progress to non-alcoholic steatohepatitis (NASH), cirrhosis, and even hepatocellular carcinoma. Given the absence of effective treatments to halt its progression, novel molecular approaches to the NAFLD diagnosis and treatment are of paramount importance. Methods: Firstly, we downloaded oxidative stress-related genes from the GeneCards database and retrieved NAFLD-related datasets from the GEO database. Using the Limma R package and WGCNA, we identified differentially expressed genes closely associated with NAFLD. In our study, we identified 31 intersection genes by analyzing the intersection among oxidative stress-related genes, NAFLD-related genes, and genes closely associated with NAFLD as identified through Weighted Gene Co-expression Network Analysis (WGCNA). In a study of 31 intersection genes between NAFLD and Oxidative Stress (OS), we identified three hub genes using three machine learning algorithms: Least Absolute Shrinkage and Selection Operator (LASSO) regression, Support Vector Machine - Recursive Feature Elimination (SVM-RFE), and RandomForest. Subsequently, a nomogram was utilized to predict the incidence of NAFLD. The CIBERSORT algorithm was employed for immune infiltration analysis, single sample Gene Set Enrichment Analysis (ssGSEA) for functional enrichment analysis, and Protein-Protein Interaction (PPI) networks to explore the relationships between the three hub genes and other intersecting genes of NAFLD and OS. The distribution of these three hub genes across six cell clusters was determined using single-cell RNA sequencing. Finally, utilizing relevant data from the Attie Lab Diabetes Database, and liver tissues from NASH mouse model, Western Blot (WB) and Reverse Transcription Quantitative Polymerase Chain Reaction (RT-qPCR) assays were conducted, this further validated the significant roles of CDKN1B and TFAM in NAFLD. Results: In the course of this research, we identified 31 genes with a strong association with oxidative stress in NAFLD. Subsequent machine learning analysis and external validation pinpointed two genes: CDKN1B and TFAM, as demonstrating the closest correlation to oxidative stress in NAFLD. Conclusion: This investigation found two hub genes that hold potential as novel targets for the diagnosis and treatment of NAFLD, thereby offering innovative perspectives for its clinical management.

Indexed as

Liver NeoplasmsNon-alcoholic Fatty Liver DiseaseAnimalsBiomarkersGene Expression ProfilingGenes, cdcMiceBiomarkersbioinformatic analysisCDKN1Bmachine learningNDUFA4non-alcoholic fatty liver diseaseTFAMWGCNA

Identifiers

PMID38476236
PMCPMC10927810
OpenAlexW4392195280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.